NEUROIMAGING AND NEURODEVELOPMENTAL OUTCOME: A SECONDARY TO SURFACTANT

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究着眼于两种不同的测试程序，超声波和脑磁共振成像[MRI]，以确定其中一种测试在预测极早产儿的神经结果方面是否更好。这项研究将收集成像研究的信息，并将其与在支持试验中收集的数据结合使用，以了解更多关于早产儿的医疗问题，如脑损伤，以及神经和发育结果。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study looks at two different testing procedures, ultrasounds and brain magnetic resonance imaging [MRI], to see if one test is better at predicting neurological outcome in extremely premature babies. This study will gather information on imaging studies and use it together with data collected in the SUPPORT Trial to learn more about medical problems of premature infants such as brain injury, and neurological and developmental outcome.